Clinical trial
A Single-Center, Single-Arm, Phase I Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
NCT06902792 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Single-Arm, Phase I Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Phase
- Phase 1
- Overall status
- Enrolling by invitation
- Start date
- February 6, 2025
- Completion date
- February 2, 2026
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.